Announce Date | 09/04/2025 |
EPS Normalized Actual | $1.26 (Beat by $0.57) |
EPS GAAP Actual | $1.26 (Beat by $0.57) |
Revenue Actual | $0.341312B |
Revenue Surprise | Beat by $341.312M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Apr 2028 | 8.62 | 4.1 | 8.46541 | 8.76341 | 1 |
Apr 2026 | 10.8 | 3.28 | 10.8 | 10.8 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ3 2025 (Jul 2025) | -0.69 | -0.69 | 0.341312B | 100% | 341.31M |
FQ2 2025 (Apr 2025) | 1.29 | 1.29 | 0.309702B | 100% | 309.7M |
FQ1 2025 (Jan 2025) | 0 | 0 | 0.263484B | 100% | 263.48M |
FQ4 2024 (Oct 2024) | 0.51 | 0.51 | 0B | NAN% | 0M |
FQ3 2023 (Jul 2023) | 0.65 | 0.65 | 0.368025B | 6.29% | 368.03M |
FQ2 2023 (Apr 2023) | 0.33 | 0.33 | 0.018133B | -1840.31% | 18.13M |
FQ1 2023 (Jan 2023) | 0.24 | 0.24 | 0.32653B | 100% | 326.53M |
FQ4 2022 (Oct 2022) | 0.49 | 0.49 | 0.35184B | 100% | 351.84M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Jan 2028) | 2.97 | -- | 2.93194 | 3.00806 | 1 |
FQ4 2027 (Oct 2027) | 1.43 | -- | 1.41168 | 1.44832 | 1 |
FQ3 2027 (Jul 2027) | 1.85 | -- | 1.82629 | 1.87371 | 1 |
FQ2 2027 (Apr 2027) | 2.87 | -- | 2.87 | 2.87 | 0 |
FQ1 2027 (Jan 2027) | 2.24 | -- | 2.11967 | 2.37557 | 0 |
FQ4 2026 (Oct 2026) | 2.02 | -- | 2.02 | 2.02 | 0 |
FQ3 2026 (Jul 2026) | 1.41 | 148.94 | 1.41 | 1.41 | 0 |
FQ2 2026 (May 2026) | 1.43667 | 10.21 | 1.40956 | 1.45861 | 0 |
FQ1 2026 (Jan 2026) | 0.71 | -- | 0.67186 | 0.75297 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Jan 2028) | 0.43B | -- | 0.43B | 0.44B | 1 |
FQ4 2027 (Oct 2027) | 0.41B | -- | 0.41B | 0.41B | 1 |
FQ3 2027 (Jul 2027) | 0.39B | -- | 0.39B | 0.4B | 1 |
FQ2 2027 (Apr 2027) | 0.36B | -- | 0.36B | 0.36B | 1 |
FQ1 2027 (Jan 2027) | 0.33B | -- | 0.32B | 0.34B | 1 |
FQ4 2026 (Oct 2026) | 0.35B | -- | 0.35B | 0.35B | 1 |
FQ3 2026 (Jul 2026) | 0.34B | -1.87 | 0.34B | 0.34B | 1 |
FQ2 2026 (May 2026) | 0.37B | 17.24 | 0.37B | 0.38B | 1 |
FQ1 2026 (Jan 2026) | 0.31B | 14.97 | 0.3B | 0.32B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2025 (Jul 2025) | -0.69 | -0.69 | 100% | |
FQ2 2025 (Apr 2025) | 1.29 | 1.29 | 100% | |
FQ1 2025 (Jan 2025) | 0 | 0 | NAN% | |
FQ4 2024 (Oct 2024) | 0.51 | 0.51 | 100% | |
FQ3 2023 (Jul 2023) | 0.65 | 0.65 | 100% | |
FQ2 2023 (Apr 2023) | 0.33 | 0.33 | 100% | |
FQ1 2023 (Jan 2023) | 0.24 | 0.24 | 100% | |
FQ4 2022 (Oct 2022) | 0.49 | 0.49 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ3 2025 (Jul 2025) | $0B | $0.34B | $341.31M | 100% |
FQ2 2025 (Apr 2025) | $0B | $0.31B | $309.7M | 100% |
FQ1 2025 (Jan 2025) | $0B | $0.26B | $263.48M | 100% |
FQ4 2024 (Oct 2024) | $0B | $0B | $0M | NAN% |
FQ3 2023 (Jul 2023) | $0B | $0.37B | $368.03M | 100% |
FQ2 2023 (Apr 2023) | $0B | $0.02B | $18.13M | 100% |
FQ1 2023 (Jan 2023) | $0B | $0.33B | $326.53M | 100% |
FQ4 2022 (Oct 2022) | $0B | $0.35B | $351.84M | 100% |